P Michael Ho1, Colin I O'Donnell2, Steven M Bradley2, Gary K Grunwald2, Christian Helfrich3, Michael Chapko3, Chuan-Fen Liu3, Thomas M Maddox2, Thomas T Tsai2, Robert L Jesse4, Stephan D Fihn5, John S Rumsfeld2. 1. Veterans Affairs Eastern Colorado Health Care System, Denver, Colorado; Division of Cardiology, University of Colorado Denver, Denver, Colorado. Electronic address: michael.ho@va.gov. 2. Veterans Affairs Eastern Colorado Health Care System, Denver, Colorado; Division of Cardiology, University of Colorado Denver, Denver, Colorado. 3. Veterans Affairs Puget Sound Health Care System, Seattle, Washington. 4. Department of Veteran Affairs, Veterans Health Administration, Washington, DC. 5. Veterans Affairs Puget Sound Health Care System, Seattle, Washington; Veterans Affairs Office of Analytics and Business Intelligence, Washington, DC.
Abstract
BACKGROUND: There is significant interest in measuring health care value, but this concept has not been operationalized in specific patient cohorts. The longitudinal outcomes and costs for patients after percutaneous coronary intervention (PCI) provide an opportunity to measure an aspect of health care value. OBJECTIVES: This study evaluated variations in 1-year outcomes (risk-adjusted mortality) and risk-standardized costs of care for all patients undergoing PCI in the Veterans Affairs (VA) system from 2007 to 2010. METHODS: This retrospective cohort study evaluated all veterans undergoing PCI at any of 60 hospitals in the VA health care system, using data from the national VA Clinical Assessment, Reporting, and Tracking (CART) program. Primary outcomes were 1-year mortality and costs following PCI. Risk-standardized mortality and cost ratios were calculated, adjusting for cardiac and noncardiac comorbidities. RESULTS: A median of 261 PCIs were performed in the 60 hospitals during the study period. Median 1-year unadjusted hospital mortality rate was 6.13%. Four hospitals were significantly above the 1-year risk-standardized median mortality rate, with median mortality ratios ranging from 1.23 to 1.28. No hospitals were significantly below median mortality. Median 1-year total unadjusted hospital costs were $46,302 per patient. There were 16 hospitals above and 19 hospitals below the risk-standardized median cost, with risk-standardized ratios ranging from 0.45 to 2.09, reflecting a much larger magnitude of variability in costs than in mortality. CONCLUSIONS: There is much smaller variation in 1-year risk adjusted mortality than in risk-standardized costs after PCI in the VA. These findings suggest that there are opportunities to improve PCI value by reducing costs without compromising outcomes. This approach to evaluating outcomes and costs together may be a model for other health systems and accountable care organizations interested in operationalizing value measurement.
BACKGROUND: There is significant interest in measuring health care value, but this concept has not been operationalized in specific patient cohorts. The longitudinal outcomes and costs for patients after percutaneous coronary intervention (PCI) provide an opportunity to measure an aspect of health care value. OBJECTIVES: This study evaluated variations in 1-year outcomes (risk-adjusted mortality) and risk-standardized costs of care for all patients undergoing PCI in the Veterans Affairs (VA) system from 2007 to 2010. METHODS: This retrospective cohort study evaluated all veterans undergoing PCI at any of 60 hospitals in the VA health care system, using data from the national VA Clinical Assessment, Reporting, and Tracking (CART) program. Primary outcomes were 1-year mortality and costs following PCI. Risk-standardized mortality and cost ratios were calculated, adjusting for cardiac and noncardiac comorbidities. RESULTS: A median of 261 PCIs were performed in the 60 hospitals during the study period. Median 1-year unadjusted hospital mortality rate was 6.13%. Four hospitals were significantly above the 1-year risk-standardized median mortality rate, with median mortality ratios ranging from 1.23 to 1.28. No hospitals were significantly below median mortality. Median 1-year total unadjusted hospital costs were $46,302 per patient. There were 16 hospitals above and 19 hospitals below the risk-standardized median cost, with risk-standardized ratios ranging from 0.45 to 2.09, reflecting a much larger magnitude of variability in costs than in mortality. CONCLUSIONS: There is much smaller variation in 1-year risk adjusted mortality than in risk-standardized costs after PCI in the VA. These findings suggest that there are opportunities to improve PCI value by reducing costs without compromising outcomes. This approach to evaluating outcomes and costs together may be a model for other health systems and accountable care organizations interested in operationalizing value measurement.
Authors: Daniel M Alyesh; Milan Seth; David C Miller; James M Dupree; John Syrjamaki; Devraj Sukul; Simon Dixon; Eve A Kerr; Hitinder S Gurm; Brahmajee K Nallamothu Journal: Circ Cardiovasc Qual Outcomes Date: 2018-06
Authors: Pranav Kansara; Sandra Weiss; William S Weintraub; Matthew C Hann; James Tcheng; S Tanveer Rab; Lloyd W Klein Journal: JACC Cardiovasc Interv Date: 2015-11 Impact factor: 11.195
Authors: Peter W Groeneveld; Elina L Medvedeva; Lorrie Walker; Andrea G Segal; Diane M Menno; Andrew J Epstein Journal: JAMA Netw Open Date: 2019-07-03
Authors: Murat Cimci; Jawed Polad; Mamas Mamas; Andres Iniguez-Romo; Bernard Chevalier; Rajpal Abhaichand; Adel Aminian; Ariel Roguin; Gabriel Maluenda; Michael Angioi; Graham Cassel; Shoichi Kuramitsu; Lotte Jacobs; Roxane Debrus; Fazila Malik; David Hildick-Smith; Peep Laanmets; Marco Roffi Journal: Heart Date: 2022-07-27 Impact factor: 7.365
Authors: Alexander C Perino; Jun Fan; Susan K Schmitt; Daniel W Kaiser; Paul A Heidenreich; Sanjiv M Narayan; Paul J Wang; Andrew Y Chang; Mintu P Turakhia Journal: J Cardiovasc Electrophysiol Date: 2018-06-22